Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase

Bioorg Med Chem Lett. 2021 May 1:39:127904. doi: 10.1016/j.bmcl.2021.127904. Epub 2021 Mar 6.

Abstract

Free Energy Perturbation (FEP) calculations can provide high-confidence predictions of the interaction strength between a ligand and its protein target. We sought to explore a series of triazolopyrimidines which bind to the EED subunit of the PRC2 complex as potential anticancer therapeutics, using FEP calculations to inform compound design. Combining FEP predictions with a late-stage functionalisation (LSF) inspired synthetic approach allowed us to rapidly evaluate structural modifications in a previously unexplored region of the EED binding site. This approach generated a series of novel triazolopyrimidine EED ligands with improved physicochemical properties and which inhibit PRC2 methyltransferase activity in a cancer-relevant G401 cell line.

Keywords: EED; EZH2; Free Energy Perturbation; Late stage functionalisation; PRC2.

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Design*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Ligands
  • Microsomes, Liver / chemistry
  • Microsomes, Liver / metabolism
  • Molecular Structure
  • Polycomb Repressive Complex 2 / antagonists & inhibitors*
  • Polycomb Repressive Complex 2 / metabolism
  • Purines / chemical synthesis
  • Purines / chemistry
  • Purines / pharmacology*
  • Quantum Theory
  • Structure-Activity Relationship
  • Thermodynamics*

Substances

  • Enzyme Inhibitors
  • Ligands
  • Purines
  • triazolopyrimidinone
  • Polycomb Repressive Complex 2